C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2004
12/15/2004	CN1555414A Plant-derived resistance gene
12/15/2004	CN1555411A Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1554664A Compounds and methods for diagnosis of tuberculosis
12/14/2004	US6831207 For incorporating into porphyrin during chlorophyll biosynthesis; qualitative/quantitative analysis
12/14/2004	US6831167 Mutants of the factor VII-activating protease and detection methods using specific antibodies
12/14/2004	US6831156 Nuclear protein for use in the prevention and treatment of cell proliferation disorders
12/14/2004	US6831151 Mast cell-specific signal transducing molecules and cDNAs thereof
12/14/2004	US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders
12/14/2004	US6830937 Antibodies inhibit B-cells from binding CD28; animal immunization/vaccines; screening; fusion
12/14/2004	US6830924 For anticarcinogenic drugs; kits
12/14/2004	US6830914 RGS-containing molecules and uses thereof
12/14/2004	US6830913 ABCB9 transporter and uses thereof
12/14/2004	US6830896 Process for analyzing annexin-V in urine, and application thereof
12/14/2004	US6830895 Method and kit for typing feline blood
12/14/2004	US6830894 Compounds and methods for modulating claudin-mediated functions
12/14/2004	US6830752 Comprises monoclonal sheep-derived antibodies and engineered antibody constructs, such as humanized single-chain Fv fragments and chimeric antibodies
12/14/2004	US6830751 Use of IL-12 antagonists in the treatment of rheumatoid arthritis
12/14/2004	CA2235038C Use of a tnf alpha antagonist for treating neurogenic skin redness
12/14/2004	CA2104957C Redirection of cellular immunity by receptor chimeras
12/09/2004	WO2004107618A2 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
12/09/2004	WO2004106917A2 Method for the selection of epitopes for immunotherapy
12/09/2004	WO2004106532A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b
12/09/2004	WO2004106515A1 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer containing the same
12/09/2004	WO2004106514A1 Method of recovering protein by deubiquitinating ubiquitinated protein
12/09/2004	WO2004106385A2 Monoclonal antibodies specific for buprenorphine and metabolites thereof
12/09/2004	WO2004106384A1 Antibodies to masp-2
12/09/2004	WO2004106383A1 Pharmaceutical composition comprising a bispecific antibody for epcam
12/09/2004	WO2004106382A1 Antibody and use thereof
12/09/2004	WO2004106381A1 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
12/09/2004	WO2004106380A2 Human-anti-human cd3 binding molecules
12/09/2004	WO2004106379A1 Immunotherapy of rectal cancer
12/09/2004	WO2004106378A2 Method of treating corneal transplant rejection by using vegf antagonists
12/09/2004	WO2004106377A1 Methods for producing antibodies
12/09/2004	WO2004106376A1 Compositions comprising large and small binding fragments of antibodies against the same toxin
12/09/2004	WO2004106375A1 Fab library for the preparation of anti vegf and anti rabies virus fabs
12/09/2004	WO2004106367A2 Enterococcus antigens
12/09/2004	WO2004106366A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
12/09/2004	WO2004105793A2 Soluble clca-1 and antagonists to clca-1
12/09/2004	WO2004105792A1 Composition against parvovirus infection
12/09/2004	WO2004105573A2 Method of diagnosis of cancer based on gene expression profiles in cells
12/09/2004	WO2004089990A9 New monoclonal antibody capable of binding integrin alpha 10 beta 1
12/09/2004	WO2004083249A3 Antibodies against human il-21 receptor and uses therefor
12/09/2004	WO2004058183A3 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents
12/09/2004	WO2004056874A3 Neuropilin-1 inhibitors
12/09/2004	WO2004043344A3 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
12/09/2004	WO2004039337A3 Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization
12/09/2004	WO2004038003A3 Human polypeptides encoded by polynucleotides and methods of their use
12/09/2004	WO2004032829A3 Immunostimulatory compositions and methods of stimulating an immune response
12/09/2004	WO2004028473A3 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
12/09/2004	WO2004005531A3 Targeting and tracking of cells to specific organs and tissues in vivo
12/09/2004	WO2003097697A3 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
12/09/2004	WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
12/09/2004	WO2003087131A3 Anti-her2 antibody variants
12/09/2004	WO2003080808A3 Novel compositions and methods in cancer
12/09/2004	WO2003066660A3 A PAIR OF ANTIBODY Fv FRAGMENTS STABILIZED BY COILEDCOIL PEPTIDES
12/09/2004	WO2003014142A3 Phosphorylated histone h2b as an apoptosis marker
12/09/2004	US20040250307 Transgenic avian species for making human and chimeric antibodies
12/09/2004	US20040249892 Secure header information for multi-content e-mail
12/09/2004	US20040249145 Using carcinoembryonic antigen expression as diagnostic and prognostic indicator of cell proliferative disorders
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040249135 Using high energy electromagnetic waves to destroy viral, prion, bacterial, fungal and parasitic contaminants in immunoglobulin; antibody purity and immunotherapy
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249124 Viral protein for use in generation of immunogllobulins to prevent lymphadenopathy associated viral infections; immunotherapy; viricides
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248799 Compositions and methods for treating cancer and hyperproliferative disorders
12/09/2004	US20040248798 Contraceptive methods and compositions related to proteasomal interference
12/09/2004	US20040248791 Insect g protein-coupled receptor genes and uses thereof
12/09/2004	US20040248781 Therapeutic method for reducing angiogenesis
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248257 Spleen expressed cell surface protein (SPLEX) for use in treatment and prevention autoimmunity, cancer, transplant rejection and inflammation
12/09/2004	US20040248254 ACPL DNA and polypeptides
12/09/2004	US20040248253 Methods and compositions for polypeptide engineering
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248224 Detection of antibodies to squalene in serum
12/09/2004	US20040248222 Monoclonal antibodies specific for buprenorphine and metabolites thereof
12/09/2004	US20040248220 Using cadherin expression as diagnostic and prognostic indicator of tumor cell expression and/or progression
12/09/2004	US20040248219 Methods for diagnosing and evaluating cancer
12/09/2004	US20040248215 Immunoglobulin fusion comprising human chorionic gonadotropin component for use in treatment and prevention of viral infection and cell proliferative disorders
12/09/2004	US20040248211 Hybridoma cell line comprising intracellular adhesion molecules for use in generating immunoglobulins to treatment autoimmune, skin and inflammatory disorders
12/09/2004	US20040248210 A molecule of the antigen binding portion phosphoryalated at residue Ser211 or Ser226 of a specific amino acid sequence; determining glucocorticoid receptors in cells from human glucocorticoid responsive tissue; agonist screening
12/09/2004	US20040248206 Connective tissue growth factor antibodies
12/09/2004	US20040248201 Recognition molecules interacting specifically with the active site or cleft of a target molecule
12/09/2004	US20040248196 Methods of screening based on the egf receptor crystal structure
12/09/2004	US20040248180 Nucleotide sequences coding modified chromgenic and/or fluorescent protein for use as diagnostic indicators in genetic engineering
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040248155 Novel oncogene, recombinant protein derived therefrom, and uses thereof
12/09/2004	US20040248137 Human and mammalian stem cell-derived neuron survival polypeptides
12/09/2004	US20040248115 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages
12/09/2004	US20040248082 especially having at least one human CDR, prepared by providing a host cell or transgenic animal or transgenic plant or plant cell capable of expressing in recoverable amounts said antibody.
12/09/2004	US20040247621 Combination therapy using a synergistic mixture of mechlorethamine, nitrogen mustard N-oxide, melphalan, uramustin, ifosfamide, chlorambucil, or cyclophosphamide and an anti-interleukin-6 receptor antibody; anticarcinogenic agents
12/09/2004	US20040247616 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
12/09/2004	US20040247614 Lysine-acyetylated tat proteins of a human immunodeficiency virus; specifically binding antibodies; vaccination to inhibit transcriptional activation
12/09/2004	US20040247611 Immunoassay for identifying pathogen-ligand interactions under shear conditions; vaccines containing an anti-adhesive monoclonal antibody, an adhesive peptide, or a pathogen adhesin
12/09/2004	US20040247610 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations
12/09/2004	US20040247605 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
12/09/2004	US20040247603 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation

1 ... 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 ... 1494